Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. No specific discussion or indication about raising capital via debt or equity was provided during the call. The focus was mainly on operational performance, capacity expansion through internal accruals (Rs. 250 crore investment at Dahej site), and growth strategies. Any new product diversification or expansion plans are underway but no timelines or funding sources were disclosed. The company remains optimistic about growth supported by strategic initiatives without discussing external fundraising.

Any current/future capex/capital investment/strategic investment?

NOCIL Limited has approved a Rs. 250 crore capital investment for expanding rubber chemical capacities at its Dahej site. The expansion is focused on existing rubber chemical segments (specific product details confidential). The new capacity is targeted at products already at or near peak utilization. The commissioning of this new capacity is expected in approximately 2.5 years, potentially starting commercial activity in the latter half of FY26-27. The company is also working on diversification into new chemistries beyond rubber chemicals; however, these are at different stages and no specifi

Future growth expectations in sales/revenue/volumes?

Overall volume growth for FY24 was about 2%, with domestic volumes flattish and exports growing 9%. Export volumes showed a 9% increase in FY24, contributing to growth despite geopolitical and raw material price challenges. Q4 FY24 volumes rose 12% sequentially, driven by both domestic (high single digits) and exports (higher double digits). Volume growth is expected to continue, building on new and existing customer traction. Revenue for FY24 was Rs. 1,445 crores, down from Rs. 1,617 crores in FY23, impacted by price declines. Selling prices saw a decline (6.5% Q-o-Q in Q4), impacting revenue

Future growth expectations in earnings/operating earnings/profits/EPS?

NOCIL sees volume growth continuing, building on a positive trajectory with new customers acquired in the past 9-12 months. Confidence in additional volume placements to customers is higher now compared to 8-12 months ago due to successful strategic engagements. Despite current margin pressures from raw material prices and pricing competition, the company expects margin stabilization as conditions normalize and Chinese market parameters improve. EBITDA margins are expected to stabilize; FY24 margins dropped by 220 bps but outlook is for recovery as the industry rebounds. The Rs. 250 cr

NOCIL LtdQ4 FY24Chemicals & Petrochemicals

NOCIL Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹145.35P/E: 34.9Market Cap: ₹2.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Overall volume growth for FY24 was about 2%, with domestic volumes flattish and exports growing 9%.
Export volumes showed a 9% increase in FY24, contributing to growth despite geopolitical and raw material price challenges.
Q4 FY24 volumes rose 12% sequentially, driven by both domestic (high single digits) and exports (higher double digits).
Volume growth is expected to continue, building on new and existing customer traction.
Revenue for FY24 was Rs. 1,445 crores, down from Rs. 1,617 crores in FY23, impacted by price declines.
Selling prices saw a decline (6.5% Q-o-Q in Q4), impacting revenue despite volume growth.
Future volume growth anticipated to continue quarter-on-quarter, with Q4 FY24 volumes as the base.
Capacity expansion planned (commissioning expected around FY26-27) aims to support growth, especially in products at peak utilization.
Diversification into new chemistries is underway but without a definitive timeline for launch.

Margin guidance

Category 3

NOCIL sees volume growth continuing, building on a positive trajectory with new customers acquired in the past 9-12 months.
Confidence in additional volume placements to customers is higher now compared to 8-12 months ago due to successful strategic engagements.
Despite current margin pressures from raw material prices and pricing competition, the company expects margin stabilization as conditions normalize and Chinese market parameters improve.
EBITDA margins are expected to stabilize; FY24 margins dropped by 220 bps but outlook is for recovery as the industry rebounds.
The Rs. 250 crore capacity expansion at Dahej is targeted for commissioning in FY26-27, expected to support growth and supply reliability.
Diversification into new chemistries is underway, which may enhance future revenue streams beyond flagship rubber chemicals.
Management remains optimistic about sustained growth supported by strong market fundamentals and strategic initiatives.

See what NOCIL Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The transcript does not mention any current or planned fundraising through debt or equity.
No specific discussion or indication about raising capital via debt or equity was provided during the call.
The focus was mainly on operational performance, capacity expansion through internal accruals (Rs. 250 crore investment at Dahej site), and growth strategies.
Any new product diversification or expansion plans are underway but no timelines or funding sources were disclosed.
The company remains optimistic about growth supported by strategic initiatives without discussing external fundraising.

Order book

The transcript does not explicitly mention the current or expected orderbook or pending orders for NOCIL Limited. However, insights related to demand and customer engagements include: - NOCIL has seen positive traction from strategic customer engagements internationally, contributing to export growth despite challenging markets. - Volume growth in Q4 FY24 included contributions from both existing and new customers, roughly evenly distributed. - Confidence levels of securing additional volumes have improved compared to 8-12 months ago, reflecting ongoing customer engagements. - The company is pursuing capacity expansions focused on products already near peak utilization to meet anticipated demand growth. - Market growth expectations and positive developments in strategic partnerships indicate an optimistic outlook on future orders and volumes, even amid external challenges like Chinese dumping and global geopolitical tensions. No specific numeric orderbook or pending order figures were disclosed.

See what NOCIL Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

NOCIL Limited has approved a Rs. 250 crore capital investment for expanding rubber chemical capacities at its Dahej site.
The expansion is focused on existing rubber chemical segments (specific product details confidential).
The new capacity is targeted at products already at or near peak utilization.
The commissioning of this new capacity is expected in approximately 2.5 years, potentially starting commercial activity in the latter half of FY26-27.
The company is also working on diversification into new chemistries beyond rubber chemicals; however, these are at different stages and no specific timeline is provided.
Strategic engagements with customers internationally are gaining traction, supporting growth prospects tied to these investments.
NOCIL is also focused on operational efficiencies and sustainability initiatives alongside capacity expansion.

Track NOCIL Ltd — get its next earnings analysis in your feed

How does NOCIL Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisNOCIL Ltd

Rev 4Mar 3

See where NOCIL Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does NOCIL Ltd rank in Chemicals & Petrochemicals?

Compare NOCIL Ltd against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What NOCIL Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →